Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Burkitt's Lymphoma

Prospective analysis of minimal bone marrow infiltration in pediatric Burkitt's lymphomas by long-distance polymerase chain reaction for t(8;14)(q24;q32)

Abstract

The chromosomal translocation t(8;14)(q24;q32) represents a characteristic marker for Burkitt's lymphoma (BL). This translocation involves the MYC oncogene on chromosome 8 and the immunoglobulin heavy-chain (IgH) locus on chromosome 14. Since the translocation does not produce a fusion gene, we established a long-distance polymerase chain reaction (LD-PCR) assay that can detect the t(8;14) at the genomic level. The sensitivity of the LD-PCR was 10−4. We used the LD-PCR assay to prospectively study 78 BL patients and found a specific PCR product in 52 of them. Among the 52 positive patients, we could test both the tumor and the bone marrow (BM) at diagnosis in 33 and determined the prevalence of minimal disseminated disease (MDD) at diagnosis. In 12/33 patients, BM was positive by LD-PCR and in 10 of them we conducted a study of minimal residual disease (MRD). Eight out of 10 children showed a clearance of MRD after one cycle of chemotherapy. The only two patients who did not achieve a negative MRD status died of disease progression. The comparative analysis of sensitivity of BM aspirate, BM biopsy and LD-PCR in t(8;14)-positive patients demonstrated a superiority of the molecular method in the assessment of MDD. The LD-PCR for t(8;14) is an important tool to study minimal BM infiltration at diagnosis and to determine its response kinetics in BL.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Shad A, Magrath I . Malignant non-Hodgkin's lymphomas in children. In: Pizzo PA, Poplack DG (eds). Principle and Practice of Pediatric Oncology, 3rd edn. Philadelphia: Lippincott-Raven, 1997, pp 545–587.

    Google Scholar 

  2. Dalla Favera R, Bregni M, Erikson J, Patterson D, Gallo RC, Croce CM . Human c-myc oncogene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci USA 1982; 79: 7824–7827.

    Article  CAS  Google Scholar 

  3. Pelicci PG, Knowles DMd, Magrath I, Dalla Favera R . Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma. Proc Natl Acad Sci USA 1986; 83: 2984–2988.

    Article  CAS  Google Scholar 

  4. Basso K, Frascella E, Zanesco L, Rosolen A . Improved long- distance polymerase chain reaction for the detection of t(8; 14)(q24;q32) in Burkitt's lymphomas. Am J Pathol 1999; 155: 1479–1485.

    Article  CAS  Google Scholar 

  5. Akasaka T, Muramatsu M, Ohno H, Miura I, Tatsumi E, Fukuhara S et al. Application of long-distance polymerase chain reaction to detection of junctional sequences created by chromosomal trans-location in mature B-cell neoplasm. Blood 1996; 88: 985–994.

    CAS  PubMed  Google Scholar 

  6. Reiter A, Schrappe M, Tiemann M, Ludwig WD, Yakisan E, Zimmermann M et al. Improved treatment results in childhood B-cell neoplasms with tailored intensification therapy: a report of the Berlin–Frankfurt–Munster group trial NHL-BFM90. Blood 1999; 94: 3294–3306.

    CAS  PubMed  Google Scholar 

  7. Shiramizu B, Magrath I . Localization of breakpoints by polymerase chain reactions in Burkitt's lymphoma with 8;14 translocations. Blood 1990; 9: 1848–1852.

    Google Scholar 

  8. Siebert R, Matthiesen P, Harder S, Zhang Y, Borowski A, Zulke-Jenisch R et al. Application of interphase fluorescence in situ hybridization for the detection of the Burkitt translocation t(8;14)(q24;q32) in B-cell lymphomas. Blood 1998; 3: 984–990.

    Google Scholar 

  9. Corradini P, Laddetto M, Pileri A, Tarella C . Clinical relevance of minimal residual disease monitoring in non-Hodgkin's lymphomas: a critical reappraisal of molecular strategies. Leukemia 1999; 13: 1691–1695.

    Article  CAS  Google Scholar 

  10. Cairo MS, Krailo MD, Morse M, Hutchinson RJ, Harris RE, Kjeldsberg CR et al. Long-term follow-up of short intensive multiagent chemotherapy without high-dose methotrexate (Orange) in children with advanced non-lymphoblastic non-Hodgkin's lymphoma: a children's cancer study group report. Leukemia 2002; 16: 594–600.

    Article  CAS  Google Scholar 

  11. Csako G, Ian TM, Ronald JE . Serum total and isoenzyme lactate dehydrogenase activity in American Burkitt's lymphoma patients. Am J Clin Pathol 1982; 78: 712–717.

    Article  CAS  Google Scholar 

  12. Gribben JG, Neuberg D, Freedman AS, Gimmi CD, Pesek KW, Barber M et al. Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma. Blood 1993; 81: 3449–3457.

    CAS  Google Scholar 

  13. Scimè R, Indovina A, Santoro A, Musso M, Olivieri A, Trincali S et al. PBSC mobilization, collection and positive selection in patients with chronic lymphocytic leukemia. Bone Marrow Transplant 1998; 22: 1159–1165.

    Article  Google Scholar 

  14. Provan D, Bartlett-Pandite L, Zwicky C, Neuberg D, Maddocks A, Corradini P et al. Eradication of polymerase chain-reaction detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone marrow transplantation. Blood 1996; 88: 2228–2235.

    CAS  Google Scholar 

  15. Zutter MM, Hess JL . Guidelines for the diagnosis of leukemia or lymphoma in children. Am J Clin Pathol 1998; 109 (Suppl 1) S9–S22.

    CAS  PubMed  Google Scholar 

  16. Murphy SB, Caces J . Limited utility of bone marrow biopsy in staging children with non-Hodgkin's lymphoma (NHL). Blood 1978; 52 (Suppl 1): 265.

    Google Scholar 

  17. Murphy SB . Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphoma in adults. Semin Oncol 1980; 7: 332–339.

    CAS  PubMed  Google Scholar 

  18. Wollner N, Burchenal JH, Lieberman PH, Exelby P, D'Angio G, Murphy ML . Non-Hodgkin's lymphoma in children: a comparative study of two modalities of therapy. Cancer 1976; 37: 123–134.

    Article  CAS  Google Scholar 

  19. Haddy TB, Parker RI, Magrath I . Bone marrow involvement in young patients with non-Hodgkin's lymphoma: the importance of multiple bone marrow samples for accurate staging. Med Pediatr Oncol 1989; 17: 418–423.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by a grant from ‘Fondazione Città della Speranza’, by MIUR-CNR and by AIL (Associazione Italiana contro le Leucemie). A Lombardi was partially supported by Progetto Ministero della Solute 2001/01/X/000177. We are grateful to Dr S Volpato for statistical analysis and to all the clinicians and pathologists of AIEOP who contributed patients and samples to the study.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mussolin, L., Basso, K., Pillon, M. et al. Prospective analysis of minimal bone marrow infiltration in pediatric Burkitt's lymphomas by long-distance polymerase chain reaction for t(8;14)(q24;q32). Leukemia 17, 585–589 (2003). https://doi.org/10.1038/sj.leu.2402828

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402828

Keywords

This article is cited by

Search

Quick links